Compliance with the Protocol Considered Emetogenic Potential for Prophylaxis of Chemotherapy Induced Nausea and Vomiting.
10.5388/jkon.2011.11.1.58
- Author:
Ja Yun CHOI
1
;
Hyeon Jeong OH
;
Ji Young KANG
;
Min Kyoung KIM
;
Ji Eun KIM
;
Jin Ha KIM
;
Hee Suk KIM
;
So Ra PARK
;
Jeong Seon BYUN
;
Jeong Hee AN
;
Min Kyoung CHO
Author Information
1. College of Nursing, Chonnam National University, Chonnam Research Instutude of Nursing Science, Gwangju, Korea. choijy@chonnam.ac.kr
- Publication Type:Original Article
- Keywords:
Guideline Adherence;
Antineoplastic combined chemotherapy protocols;
Nausea;
Vomiting
- MeSH:
Antiemetics;
Antineoplastic Combined Chemotherapy Protocols;
Compliance;
Female;
Guideline Adherence;
Humans;
Korea;
Morning Sickness;
Nausea;
Pregnancy;
Vomiting
- From:Journal of Korean Oncology Nursing
2011;11(1):58-64
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
PURPOSE: The purpose of this study was to identify the compliance with the protocol, which was developed considering the emetogenic potential for prophylaxis of chemotherapy. METHODS: Data was collected from 144 patients who received chemotherapy from June 15 to August 31, 2010 in C University Hospital in Jeollanamdo, Korea. The level of chemotherapy-induced nausea and vomiting (CINV) and the compliance with the protocol for prophylaxis of CINV were measured. RESULTS: There was statistically significant difference of CINV in morning sickness and anticipatory nausea of general and clinical characteristics. Also, the compliance with the protocol developed according to emetogenic potential of chemotherapy was statistically significant. There was no difference in CINV in regard to the compliance with the protocol. CONCLUSION: There was a good compliance with the protocol for prophylaxis according to emetogenic potential. But it should be recommended to use antiemetics for prophylaxis aggressively to relieve CINV for the patients who already experienced morning sickness and anticipatory nausea. In addition, the oncology nurses should respond sensitively to the complaints of nausea and vomiting no matter what the emetogenic potentials of chemotherapy regimen are.
